beyond pink team
  • Home
  • About Us
    • Who We Are
    • Our Board
    • Annual Report
    • Contact Us
  • Support
    • Physical
    • Emotional
    • Community
    • Financial
    • Caregiver
    • Online
  • Education
    • Newsletter
    • Ignite the Cancer Conversation
    • Quality Care
    • Resources
    • Request Speaker
    • The Cancer Journey
  • Advocacy
    • What is Advocacy
    • National Breast Cancer Coalition
    • Iowa Stop Breast Cancer
    • Research
    • Influencing Policy
    • Access to Care
  • Join Us
    • Be an Advocate
    • Volunteer
    • Events >
      • 16th Annual Pink Ribbon Run
    • Membership
    • Donate to BPT
    • Follow Us
 If you are Breast Cancer Survivor and  you would like to contribute your story to our Newsletter, 
​please send us a message here.
DOWNLOAD Current NewsletteR

Categories

All
Advocacy
Bone Health
Breast Density
Breast Disease
Caregivers
COVID 19
COVID-19
Emotional Support
Environment
Exercise
Fatigue
Financial
Gender
Genetic Testing
Grief
High Risk
Hormone Replacement Therapy
Ignite
Implants
Intimacy After Cancer
LGBTQ
Lymphedema
Mammography
Meditation
Men
Mental Health
Metastasis
MRI
NBCC
Nutrition
Obesity
Pain
Pregnancy
Prevention
Radiation
Reconstruction
Reduce Risk
Rehabilitation
Screening
Sex
Side Effects
Support Groups
Surgery
Survivor
Survivorship
Treatment
Vaccine
Yoga
Young Women

Archives

January 2023
October 2022
July 2022
April 2022
January 2022
October 2021
July 2021
April 2021
January 2021
October 2020
July 2020
April 2020
January 2020
October 2019
July 2019
April 2019
January 2019
October 2018
July 2018
April 2018
January 2018
October 2017
July 2017
April 2017
January 2017
October 2016
July 2016
April 2016
January 2016
October 2015
July 2015
April 2015
January 2015
October 2014
July 2014
April 2014
January 2014
October 2013
July 2013
April 2013
January 2013
October 2012
July 2012
April 2012
January 2012
October 2011
July 2011
April 2011
January 2011
October 2010
July 2010
April 2010
January 2010
October 2009
July 2009
April 2009
January 2009
October 2008
July 2008
April 2008
January 2008
October 2007
July 2007
April 2007
January 2007
October 2006
July 2006
April 2006
January 2006
October 2005
July 2005
April 2005
January 2005
October 2004
July 2004
April 2004
January 2004

Neo-Adjuvant Treatment for Breast Cancer

10/1/2016

0 Comments

 

by Mary Kremer, CN-Bi, R.T. (R)(T) Certified Breast Cancer Navigator

Newer approach to breast cancer treatment for Her2 positive cancer

In the last several years there has been new management in the treatment of breast cancers that are Her2-neu positive. While examining the sample obtained during a breast biopsy, the pathologist evaluates for expression of a certain protein called Her2-neu, if the diagnosis is a breast cancer. Her2 or “human epidermal growth factor receptor 2” is a gene that helps control the growth and repair of cells.

This is a protein that appears on the surface of some breast cancer cells. Breast cancers that are Her2 positive have over-expression of the gene indicating that the gene is making too many copies of itself. Extra copies of Her2 genes tell breast cancer cells to grow and multiply. For most breast cancers, surgery is the first line of treatment. After healing of the surgical wound in about 4 – 6 weeks, then other forms of treatment tend to follow.

However, for Her2-neu positive cancers, the oncologists and surgeons may consider certain medications before surgery which is called neoadjuvant therapy. Two agents that have been used in neoadjuvant regiments are Herceptin and Perjeta. Treatment recommended after surgery is called adjuvant therapy.

A benefit of neoadjuvant treatment is that it prevents delay of administering chemotherapy to treat and prevent breast cancer spread beyond the breast, as it is given in these cases, before surgery. In patients who tend to heal slowly after having a lumpectomy or mastectomy, their treatments could be delayed, as doctors typically wait for the surgical wound to heal before administering chemotherapy.

Additionally, since neoadjuvant chemotherapy could shrink the size of cancer, the patient may now be able to have a lumpectomy with radiation, instead of a mastectomy, hence allowing breast conservation. Not every woman who has been diagnosed with a Her2 positive breast cancer may require neoadjuvant treatment.

There are many factors that the medical team considers before deciding on a course of treatment. Doctors will take into consideration multiple different factors to decide on the appropriate regiment for treatment. Some of the factors may include age, overall performance status and other medical issues which could make some patients unable to tolerate potential side effects of certain treatments.

In summary, neoadjuvant chemotherapy is available in treating specific cases of breast cancer which are Her2-neu positive which allows shrinkage of the breast cancer and treatment of cancer beyond the breast, prior to surgery. This has additional benefits of changing surgical management from mastectomy to lumpectomy, which allows breast conservation. Recent advances in research have led to a patient-centered approach where treatment is tailored to each patient based on multiple relevant patient factors. 

​
Read Full Newsletter
0 Comments



Leave a Reply.

CONTACT US

Beyond Pink TEAM
c/o Jeanne Olson, Treasurer
1407 Asbury Lane
Waterloo, IA 50701
​beyondpinkteam@gmail.com
(319) 239-3706
©2020 Beyond Pink TEAM
  • Home
  • About Us
    • Who We Are
    • Our Board
    • Annual Report
    • Contact Us
  • Support
    • Physical
    • Emotional
    • Community
    • Financial
    • Caregiver
    • Online
  • Education
    • Newsletter
    • Ignite the Cancer Conversation
    • Quality Care
    • Resources
    • Request Speaker
    • The Cancer Journey
  • Advocacy
    • What is Advocacy
    • National Breast Cancer Coalition
    • Iowa Stop Breast Cancer
    • Research
    • Influencing Policy
    • Access to Care
  • Join Us
    • Be an Advocate
    • Volunteer
    • Events >
      • 16th Annual Pink Ribbon Run
    • Membership
    • Donate to BPT
    • Follow Us